Join EVERSANA at DIA’s Pharmacovigilance and Risk Management Strategies Conference, January 27-29, in Washington, DC. The conference will provide current thinking on predicting and assessing risks, assessment of expectedness of serious adverse reactions during clinical development, the complexities of assessing benefit-risk balance of today’s therapies (including immunotherapy and other advanced therapies), and impactful uses of real world data and generation of RWE for safety assessments. A full-day will be devoted to the development, implementation, and assessment of risk management strategies for drugs approved in multiple regions, with a special in-depth coverage of REMS in the US.
Stop by Booth 3 to meet EVERSANA’s Pharmacovigilance and Medical Communications team.
Talk with our business experts to learn more about how our global solutions provide you with the right strategies and tools to help mitigate risk, improve adherence, and measure value.
